← Back
Data updated: Mar 10, 2026
SHILPA
OncologyGastroenterology
SHILPA is a generic drug manufacturer focused on Oncology, Gastroenterology. Key products include PEMETREXED.
2015
Since
12
Drugs
-
Trials
105
Approved (2yr)
Recent Activity
ZOLEDRONIC ACID 2026-02-05
CAPECITABINE 2026-01-27
Labeling
VARENICLINE TARTRATE 2026-01-09
BORTEZOMIB 2026-01-06
VARENICLINE TARTRATE 2025-12-18
Labeling
BORTEZOMIB 2025-12-17
VARENICLINE TARTRATE 2025-10-29
VARENICLINE TARTRATE 2025-09-24
Labeling
GEMCITABINE HYDROCHLORIDE 2025-09-16
Labeling
IRINOTECAN HYDROCHLORIDE 2025-08-20
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 80%
4 drugs
Gastroenterology 20%
1 drugs
Pipeline Strength Pro
Loading...
Active (6)
Discontinued (5)
Company Info
- First Approval
- 2015-12-22
- Latest
- 2025-08-04
- Applications
- 14